Lupin gets USFDA nod to market Flucytosine capsules USP of 2
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Drug firm Lupin has received nod from the USFDA to market its Flucytosine capsules USP, in the strengths of 250 mg and 500 mg which is used for treatment of serious infections caused by susceptible strains of Candida and/or Cryptococcus


http://bit.ly/2u3f4UA
Dr. M●. S●●●●●l I●●●m S●●●n and 2 other likes this
Like
Comment
Share